2021; X(X): XX-XX
ISSN: XXXX - XXXX (Print); ISSN: XXXX - XXXX (Online)
Author’s Full Name1, *
, Author’s Full Name1, 2
Department/Faculty, University, City, Country
Department, Institute/Organization, City, Country
firstname.lastname@example.org (author name1), email@example.com (author name2)
To cite this article:
Author’s Name. Paper Title. International Journal of XXXXXX. Vol. x, No. x, 2021, pp. x-x. doi: 10.11648/j.xxx.xxxxxxxx.xx.
Received: MM DD, 2021; Accepted: MM DD, 2021; Published: MM DD, 2021
Abstract: An abstract is a short summary of your research paper, usually about a paragraph (200-400 words) long. A
well-written abstract can let readers get the essence of your paper, prepare readers to follow the detailed information, analyses,
and arguments in your full paper, and help readers remember the key points.
Keywords: Keyword1, Keyword2 … Keyword8
This template, created in MS Word 2000/2007/2010 and
saved as ―Word 97-2000 & 6.0/95 – RTF‖ for the PC,
provides authors with most of the formatting specifications
needed for preparing electronic versions of their papers. All
standard paper components have been specified for three
reasons: (1) ease of use when formatting individual papers,
(2) automatic compliance to electronic requirements that
facilitate the concurrent or later production of electronic
products, and (3) conformity of style throughout a journal
publication. Margins, column widths, line spacing, and type
styles are built-in; examples of the type styles are provided
throughout this document. Some components, such as
multi-leveled equations, graphics, and tables are not
prescribed, although the various table text styles are
provided. The formatter will need to create these
components, incorporating the applicable criteria that
2. Custom Title
First, confirm that you have the correct template for your
paper size. This template has been tailored for output on the
A4 paper size.
The template is used to format your paper and style the text.
All margins, column widths, line spaces, and text fonts are
prescribed; please do not alter them. You may note
peculiarities. For example, the head margin in this template
measures proportionately more than is customary. This
measurement and others are deliberate, using specifications
that anticipate your paper as one part of the entire publication,
and not as an independent document. Please do not revise any
of the current designations.
Before you begin to format your paper, first write and save
the content as a separate text file. Keep your text and graphic
files separate until after the text has been formatted and styled.
Do not use hard tabs, and limit use of hard returns to only one
return at the end of a paragraph. Do not add any kind of
pagination anywhere in the paper. Do not number text
heads-the template will do that for you.
2.2.2. Abbreviations (SciencePG-Level3)
Define abbreviations and acronyms the first time they are
used in the text, even after they have been defined in the
abstract. Abbreviations such as IEEE, SI, MKS, CGS, sc, dc,
and rms do not have to be defined. Do not use abbreviations
in the title or heads unless they are unavoidable.
1) The article should be written in
2) An article should be between 6 and
25 pages, and exceed 2000 words.
3) The article should be composed of
title, author(s), affiliation(s), email(s),
abstract, keywords, introduction, main
body, conclusion, and references.
1) The title should be at least 7 words
but no more than 25 words.
2) The title should be a declarative
phrase without punctuation at the end
1) Please clearly indicate the full
name of each author.
2) There should be no professional
title/ranks before the author's name.
The affiliation of the author should
only include Department/Faculty,
Country or ―Company, City, Country‖.
Please write the corresponding
author’s name after each email
The number of words in the ―Abstract‖
should be at least 200 words but no
more than 400 words. The contents of
―Abstract‖ should be structured in one
paragraph without formulas, pictures
and in-text citations.
The keywords should include at least
3 words/phrases but no more than 8.
1) The headings or subheadings
should be numbered in order as the
2) Each headings or subheadings
should not exceed 3 lines.
3) There should be at least 2
subheadings but no more than 10
subheadings under one heading. For
example, there should be at least two
subheadings (such as 2.2.1 and 2.2.2)
under the heading 2.2.
2 Author Name et al.: Paper title
2.2.3. Equations (SciencePG-Level3)
The equations are an exception to the prescribed
specifications of this template. You will need to determine
whether or not your equation should be typed using either the
Times New Roman or the Symbol font (please no other font).
To create multileveled equations, it may be necessary to treat
the equation as a graphic and insert it into the text after your
paper is styled.
Equation numbers, within parentheses, are to position flush
right, as in (1), using a right tab stop. To make your equations
more compact, you may use the solidus ( / ), the exp function,
or appropriate exponents. Italicize Roman symbols for
quantities and variables, but not Greek symbols. Use a long
dash rather than a hyphen for a minus sign. Punctuate
equations with commas or periods when they are part of a
sentence, as in
Note that the equation is centered using a center tab stop. Be
sure that the symbols in your equation have been defined
before or immediately following the equation. Use ―(1)‖, not
―Eq. (1)‖ or ―equation (1)‖, except at the beginning of a
sentence: ―Equation (1) is . . .‖
3.1. Figure (SciencePG-Level2)
Figure is as follows: Place figures and tables at the top and
bottom of columns. Avoid placing them in the middle of
columns. Large figures and tables may span across both
columns. Figure captions should be below the figures; table
heads should appear above the tables. Insert figures and tables
after they are cited in the text. Use the ―Figure 1‖, even at the
beginning of a sentence.
Figure 1. The caption of the figure.
If the square-shaped pixel size in our images was 8 × 8
screen-pixels, this amounted to about 21 pixels per face
quantization (an equivalent of about 10.5 cycles/face). With
this level of image detail, all three basic varieties of configural
information (hange of spatial quantization between 11
pixels/face and 6 pixels/face levels altogether indicate that this
ERP- component is especially sensitive to the first-order
configural cues. Some other works have supported both of
(a) (b) (c)
Figure 2. There are three figures illustrated here.
3.2. Table (SciencePG-Level2)
Table is as follows: Use words rather than symbols or
abbreviations when writing Figure axis labels to avoid
confusing the reader. As an example, write the quantity
―Magnetization‖, or ―Magnetization, M‖, not just ―M‖.
Table 1. Table information
The example for this table.
3.3. In-text citations (SciencePG-Level2)
The template will number citations consecutively within
brackets . The sentence punctuation follows the bracket .
Refer simply to the reference number, as in —do not use
―Ref. ‖ or ―reference ‖ except at the beginning of a
sentence: ―Reference  was the first . . .‖
Number footnotes separately in superscripts. Place the
actual footnote at the bottom of the column in which it was
cited. Do not put footnotes in the reference list. Use letters for
Unless there are six authors or more give all authors' names;
do not use ―et al.‖. Papers that have not been published, even if
they have been submitted for publication, should be cited as
―unpublished‖ [4-8]. Papers that have been accepted for
publication should be cited as ―in press‖ [9-12]. Capitalize
only the first word in a paper title, except for proper nouns and
For papers published in translation journals, please give the
English citation first, followed by the original
foreign-language citation [13-15].
1) The formula should be editable
with no image format.
2) The superscript and subscript should
be clearly shown in a formula.
3) The formula should be numbered in
order with Arabic numerals in
parentheses after each formula.
1) Figures should be numbered in
order with clear captions.
2) The captions should be editable and
be written below the figures.
3) Figures should be numbered just
with Arabic numerals in the unified
style, such as Figure 1, Figure 2,
1) Table captions should be clear and
be put above the table.
2) All tables should be editable with no
3) Tables should be numbered with
Arabic numerals in the unified style,
such as Table 1, Table 2, Table 3...
4) The corresponding meaning of the
symbol in the table should be given
below the table.
1) The in-text citations should be
written in the unified form, such as ,
,  and so on. For example, 
should be written in a normal text form
instead of in superscript ―
2) If there are two or more sources
cited in the same sentence or
paragraph, please enclose all the
citations in one bracket, such as [2, 3],
[6-8] and [4, 9-12].
The issue name 2021; X(X): XX-XX 3
After the text edit has been completed, the paper is ready for
the template. Duplicate the template file by using the Save As
command, and use the naming convention prescribed by your
conference for the name of your paper. In this newly created
file, highlight all of the contents and import your prepared text
file. You are now ready to style your paper; use the scroll
down window on the left of the MS Word Formatting toolbar.
You as the author are free to decide whether to include
acknowledgments or not. Usually, the acknowledgments
section includes the names of people who in some way
contributed to the work, but do not fit the criteria to be listed
as the authors. This section of your manuscript can also
include information about funding sources.
 Alimehmeti, I. (2021). Efficacy and Safety of AZD1222,
BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2.
Albanian Journal Of Trauma And Emergency Surgery, 5(1),
791-796. doi: 10.32391/ajtes.v5i1.178
 Bos, F., & Ruijs, A. (2021). Quantifying the Non-Use Value of
Biodiversity in Cost–Benefit Analysis: The Dutch
Biodiversity Points. Journal Of Benefit-Cost Analysis, 12(2),
287-312. doi: 10.1017/bca.2020.27
 Bryant, A., Lawrie, T., & Fordham, E. (2021). Ivermectin for
Prevention and Treatment of COVID-19 Infection: A
Systematic Review, Meta-analysis, and Trial Sequential
Analysis to Inform Clinical Guidelines. American Journal of
Therapeutics, 28, e434–e460, July 2021. American Journal Of
Therapeutics, 28(5), e573-e576. doi:
 CZucman, N., Uhel, F., Descamps, D., Roux, D., & Ricard, J.
(2021). Severe Reinfection With South African Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant
501Y.V2. Clinical Infectious Diseases. doi:
 Drupp, M., & Hä
nsel, M. (2021). Relative Prices and Climate
Policy: How the Scarcity of Nonmarket Goods Drives Policy
Evaluation. American Economic Journal: Economic Policy,
13(1), 168-201. doi: 10.1257/pol.20180760
 Hariyanto, T., Halim, D., Rosalind, J., Gunawan, C., &
Kurniawan, A. (2021). Ivermectin and outcomes from
Covid‐19 pneumonia: A systematic review and meta‐
analysis of randomized clinical trial studies. Reviews In
Medical Virology. doi: 10.1002/rmv.2265
 Hill, A., Garratt, A., Levi, J., Falconer, J., Ellis, L., & McCann,
K. et al. (2021). Meta-analysis of randomized trials of
ivermectin to treat SARS-CoV-2 infection. Open Forum
Infectious Diseases. doi: 10.1093/ofid/ofab358
 Klompas, M. (2021). Understanding Breakthrough Infections
Following mRNA SARS-CoV-2 Vaccination. JAMA. doi:
 Kory, P., Meduri, G., Varon, J., Iglesias, J., & Marik, P. (2021).
Review of the Emerging Evidence Demonstrating the Efficacy
of Ivermectin in the Prophylaxis and Treatment of COVID-19.
American Journal Of Therapeutics, 28(3), e299-e318. doi:
 Kow, C., Merchant, H., Mustafa, Z., & Hasan, S. (2021). The
association between the use of ivermectin and mortality in
patients with COVID-19: a meta-analysis. Pharmacological
Reports, 73(5), 1473-1479. doi: 10.1007/s43440-021-00245-z
 Marciniak, S., Farrell, J., Rostron, A., Smith, I., Openshaw, P.,
& Baillie, J. et al. (2021). COVID-19 pneumothorax in the
UK: a prospective observational study using the ISARIC
WHO clinical characterisation protocol. European Respiratory
Journal, 58(3), 2100929. doi: 10.1183/13993003.00929-2021
 Mukarram, M. (2021). Ivermectin Use Associated with
Reduced Duration of Covid-19 Febrile Illness in a Community
Setting. International Journal Of Clinical Studies And Medical
Case Reports, 13(4). doi: 10.46998/ijcmcr.2021.13.000320
 Okumuş, N., Demirtürk, N., Çetinkaya, R., Güner, R., Avcı, İ.,
& Orhan, S. et al. (2021). Evaluation of the effectiveness and
safety of adding ivermectin to treatment in severe COVID-19
patients. BMC Infectious Diseases, 21(1). doi:
 Yeh, H. (2021). The Potential Declining Efficacy of the
ChAdOx1 nCoV-19 Vaccine (AZD1222) on Inoculators With
Nonsteroidal Anti-inflammatory Drug (NSAID) Intake.
Clinical Infectious Diseases. doi: 10.1093/cid/ciab516
 Zaidi, A., & Dehgani-Mobaraki, P. (2021). RETRACTED
ARTICLE: The mechanisms of action of Ivermectin against
SARS-CoV-2: An evidence-based clinical review article. The
Journal Of Antibiotics. doi: 10.1038/s41429-021-00430-5
1) This part is to list all the literature
that has been cited in the article,
including journal articles, books, web
Taking the journal article as an
example, the reference should include
the author's name, the published year,
the paper title, the journal name, the
volume and the issue, the pages.
2) Please list at least 15 references.
3) The reference should be numbered
in the unified form, such as , ,